Skip to content

Clinical trials

Completed Muscular Dystrophies trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophies Status: Completed Country / region: Germany Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20102
20132
20171
20182
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Catabasis Pharmaceuticals1
Hoffmann-La Roche1
Ludwig-Maximilians - University of Munich1
PTC Therapeutics1
Sarepta Therapeutics, Inc.1
Swiss Federal Institute of Technology1
University of Erlangen-Nürnberg Medical School1
University of Rochester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophies10
Muscular Dystrophy, Duchenne8
Neuromuscular Diseases3
Musculoskeletal Diseases2
Genetic Diseases, Inborn1
Genetic Diseases, X-Linked1
Muscle Weakness1
Muscular Diseases1
Muscular Disorders, Atrophic1
Muscular Dystrophy, Facioscapulohumeral1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.